PEMETREXED Viatris conc perf 500 mg/20ml flac
7680680400050
CH-68040
L01BA04
07.16.1.
Active substances:
Reimbursement limitations:
JANUVIA5
Pour le traitement des patients diabétiques de type 2, lorsque un régime alimentaire et une …
1 / 3
google
Details
- Product number
- 6804002
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- pemetrexedum 500 mg ut pemetrexedum diargininum, argininum, cysteinum, propylenglycolum 700 mg, acidum citricum, aqua ad iniectabile, q.s. ad solutionem pro 20 ml.
Articles (1)
Pemetrexed Viatris 500 mg, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
pemetrexedum
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
pemetrexedum diargininum
|
- | Substance | WIZUS |
|
argininum
|
- | Substance | HNIDK |
|
cysteinum
|
- | Substance | HNIDK |
|
propylenglycolum
|
700.0 MG | Substance | HBESI |
|
acidum citricum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 479.15
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/07/2021
Authorization holder
Viatris Pharma GmbH
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 68040
- Drug name
- Pemetrexed Viatris, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01BA04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 12/04/2021
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PEMETREXED Viatris conc perf 500 mg/20ml flac
- Description (DE)
- PEMETREXED Viatris Inf Konz 500 mg/20ml Durchstf
- Market launch
- 12/04/2021
- Narcotic (BTM)
- No